Elsie’s story is one of inspiration. She had a sad beginning, having been bred in a puppy mill to be sold at a pet store. At 8 weeks old, Monica purchased Elsie, unaware of her origin. As many puppy mill stories go, Elsie began having health issues at a very young age. At just 9 months old, Elsie was diagnosed with severe hip dysplasia and was in need of a hip replacement. Though many told her to put Elsie down, Monica didn’t think twice about the procedure and by 11 months of age, Elsie was given an artificial hip that brought her many years of comfort.

It wasn’t until she was about 10 years old that Elsie’s hip arthritis began to cause her back end to give out. She knew she had to do something to help Elsie be more comfortable and mobile so she sought the expert advice of Dr. Charles Bruce at Alta Vista Animal Hospital in Ontario, Canada. In 2015, Elsie received her first round of stem cell injections. Over the next 11 months, Elsie received stem cell therapy every 3-4 months and her owner reported that she was walking better, playing with her toys, swimming, and was once again enjoying life.

To read more about Elsie’s story, click here.

If you think your dog is suffering from pain, discomfort, or lameness, contact VetStem today to see if there is a veterinary stem cell provider in your area.

Last week the largest gathering in the world on healthcare convened in San Francisco. The Alliance for Regenerative Medicine (ARM) held its annual “State of the Industry” talk that reviewed 2017 and previewed 2018. It was, without doubt, the most exciting such update since ARM began this briefing.

The briefing on 2017 showed not one, but three cell therapy approvals! Although these cell therapies are directed at cancer therapy, they are cell therapy and showed that the FDA is willing to fast-track really legitimate new cell products. Perhaps more exciting to us in the adult stem cell area is the recommendation by a European Medicines committee to approve the first adipose-derived stem cell therapy for human Crohn’s Disease! This is the same type of cell therapy product that VetStem is testing for approval in veterinary medicine. This would be a first in Europe for people!

The briefing also previewed 2018 with the prospect for more approvals and they stated they expect 40 new cell products in the next five years.

VetStem is proud to be in the forefront in bringing cell therapy into the hands of the practicing veterinarian and we are grateful to the many owners who have trusted VetStem to provide Regenerative Cell Therapy for arthritis and tendon and ligament injuries for their beloved animals.

You can watch the Cell & Gene Therapies State of the Industry Briefing here.